RxSight Inc (RXST)
62.84
+1.16
(+1.88%)
USD |
NASDAQ |
May 06, 16:00
68.32
+5.48
(+8.72%)
After-Hours: 20:00
RxSight Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.1246 |
March 31, 2023 | 0.278 |
December 31, 2022 | 0.4468 |
September 30, 2022 | 0.4171 |
June 30, 2022 | 0.3626 |
Date | Value |
---|---|
March 31, 2022 | 0.3239 |
December 31, 2021 | 0.2876 |
September 30, 2021 | 0.2627 |
June 30, 2021 | -0.1261 |
March 31, 2021 | -0.0976 |
December 31, 2020 | -0.082 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.1261
Minimum
Jun 2021
0.4468
Maximum
Dec 2022
0.169
Average
0.2627
Median
Sep 2021
Debt to Equity Ratio Benchmarks
Abbott Laboratories | 0.3803 |
Alphatec Holdings Inc | 6.565 |
AtriCure Inc | 0.1356 |
Intuitive Surgical Inc | 0.00 |
iRhythm Technologies Inc | 0.1664 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 182.55M |
Total Liabilities (Quarterly) | 22.19M |
Shareholders Equity (Quarterly) | 160.36M |
Current Ratio | 8.057 |
Net Debt Paydown Yield | 0.55% |